Analyst Activity – Royal Bank of Canada Reiterates Outperform on TSO3 (TSE:TOS)

Analyst Ratings For TSO3 (TSE:TOS)

Story continues below

Today, Royal Bank of Canada reiterated its Outperform rating on TSO3 (TSE:TOS) with a price target of C$4.25.

There are 6 buy ratings on the stock.

The current consensus rating on TSO3 (TSE:TOS) is Buy (Score: 3.00) with a consensus target price of C$5.14 per share, a potential .

Some recent analyst ratings include

  • 5/3/2017-Royal Bank of Canada Reiterated Rating of Outperform.
  • 10/20/2016-National Bank Financial Reiterated Rating of Outperform.
  • 7/27/2016-Desjardins Reiterated Rating of Buy.

    About TSO3 (TSE:TOS)
    TSO3 Inc is a Canada-based company engaged in the sale, production, maintenance, research, development and licensing of sterilization processes, related consumable supplies and accessories for heat-sensitive medical devices. The Company designs products for sterile processing areas in the hospital environment. The Company’s products are used in the sterilization departments of hospital and other medical facilities. It also provides services related to the maintenance of sterilization equipment and compatibility testing of medical devices with such processes. It has developed a sterilizer using a sterilization process based on ozone as the sterilizing agent. The Company’s STERIZONE VP4 Sterilizer is a dual sterilant, low temperature sterilization system that utilizes vaporized hydrogen peroxide (H2O2) and ozone (O3) as its sterilants. The STERIZONE VP4 terminally sterilizes multiple channels in a single device.

    Recent Trading Activity for TSO3 (TSE:TOS)
    Shares of TSO3 closed the previous trading session at 3.17 up +0.08 2.59% with 46,057 shares trading hands.

    An ad to help with our costs